Bio Pharma Dive
OCTOBER 28, 2020
The companies hope Insitro's technology can lead to a deeper understanding of how ALS progresses and, in turn, help them discover better treatments.
World of DTC Marketing
OCTOBER 28, 2020
SUMMARY: Leaders have a duty to make their companies stronger and help make the world a better place. Leadership is crucial in providing a unified vision. Pharma CEO’s shouldn’t believe that their products, alone, will help make the world a stronger place. People want and need more. I believe there is a significant leadership vacuum in healthcare.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 28, 2020
Lilly will charge the U.S. $1,250 per vial of the antibody-based treatment, which is under review by the FDA for an emergency approval.
Pharma Mirror
OCTOBER 28, 2020
New clinical research conducted by the University of Sherbrooke, Canada, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, has established people with Mild Cognitive Impairment (MCI) experienced significant improvement in cognitive function when consuming a specialized ketogenic drink (BrainXpert Energy Complex) twice a day for six months.
Bio Pharma Dive
OCTOBER 28, 2020
The two Swiss firms will develop protein drugs that are meant to have similar effects as coronavirus antibodies, but would be easier to mass produce.
Camargo
OCTOBER 28, 2020
Perhaps surprisingly, the majority of nonclinical Contract Research Organisations (CROs) are not in glamorous locations. Not too many facilities are located near a beach or with beautiful mountain views, so arriving at their front door at 7:30 am on a cold and snowy Montreal morning in February isn’t on the bucket list of too many people. However, the experienced nonclinical scientist understands that no matter the duration, scope, or objectives of a study, monitoring visits are a critical part
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
OCTOBER 28, 2020
Novartis acquired Vedere Bio in a deal totaling up to $280 million. The takeout broadens Novartis’ footprint in gene and cell therapy, with Vedere Bio’s gene therapy platforms for ophthalmic disorders.
pharmaphorum
OCTOBER 28, 2020
Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients.
Pharma Times
OCTOBER 28, 2020
Acquisition will enable Base Genomics to accelerate clinical and commercial development
pharmaphorum
OCTOBER 28, 2020
The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness has been called into question. The initial agreement is for delivery over the two months following an EUA, and provides the option for the government to purchase up to an additional 650,000 vials through 30 June 2021.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
OCTOBER 28, 2020
BioSpace provides an up-to-date overview of these deals and the projected COVID-19 vaccine doses each company plans to have within the next couple of years.
XTalks
OCTOBER 28, 2020
National Chocolate Day, which occurs every year on October 28, pays tribute to one of the most popular sugary treats. Chocolate can enhance a dessert or satisfy any sweet craving — so much so that Americans spent $22 billion on chocolate in 2018, up one percent from the year prior. Not only does chocolate continue to prove itself as a money-making snack, but no other sweet treat has survived the healthy eating movement as well as it has.
BioSpace
OCTOBER 28, 2020
Texas wants to get the word out: It’s not just for oil and pipelines anymore. The Lone Star State is a rapidly emerging biopharma hub, with more than just a lone focus on oncology.
XTalks
OCTOBER 28, 2020
A new study from the University of Maryland School of Medicine (UMSOM) has found that hospitalized COVID-19 patients have a significantly lower risk of complications and death if they are taking daily low-dose aspirin as protection against cardiovascular disease, compared to those not taking the drug. The study found that aspirin users were less likely to be placed in an intensive care unit (ICU), require mechanical ventilation and were more likely to survive COVID-19 infection compared to hospi
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
OCTOBER 28, 2020
Arcus will pair its investigational anti-TIGIT antibody domvanalimab (AB154) with AstraZeneca’s Imfinzi (durvalumab), a checkpoint inhibitor, in a Phase III study with patients who have unresectable Stage III NSCLC.
XTalks
OCTOBER 28, 2020
Guinness 0.0 is the new non-alcoholic beer that keeps the famous Guinness stout flavor intact. The non-alcoholic beer from the brewers at St. James’s Gate boasts the smooth taste, balanced flavor and unique dark color that Guinness proudly produces, without the alcohol. The journey to launching Guinness 0.0 came from four years of research and innovation led by the team at the Home of Guinness.
pharmaphorum
OCTOBER 28, 2020
Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it plans to use to develop its product offering. Based in Iceland, Sidekick said the oversubscribed funding round was led by Wellington Partners and Asabys Partners through its SAHII fund, with existing investors Novator and Frumtak Ventures.
Pharma Times
OCTOBER 28, 2020
Process can help to reduce the time to authorisation of the vaccine
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
OCTOBER 28, 2020
Scientists have discovered that sodium bicarbonate – also known as baking soda or bicarbonate of soda – can reprogram T cells in leukemia patients to resist the immune-suppressing effects of cancer cells, which can drive leukemia relapse after stem cell transplants. The work clarifies why patients frequently relapse after transplant, and lays the foundation to […].
BioSpace
OCTOBER 28, 2020
THOR-707 is a non-alpha IL-2 candidate that is currently being studied in Phase I trials in solid tumors.
Scienmag
OCTOBER 28, 2020
New analysis of gravitational-wave data leads to wealth of discoveries Credit: Aaron M. Geller, Northwestern University/CIERA An international research collaboration including Northwestern University astronomers has produced the most detailed family portrait of black holes to date, offering new clues as to how black holes form. An intense analysis of the most recent gravitational-wave data available […].
Pharma Times
OCTOBER 28, 2020
Agreement will see vaccine developers make available 200 million doses
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
OCTOBER 28, 2020
Credit: University of Illinois Urbana-Champaign Ultraviolet light is a form of radiation that can be used for sterilization and disinfection. With schools and offices beginning to meet in-person again despite little change in the rate of COVID-19 infections, easy, low-cost sterilization strategies are necessary to curb the spread of the pandemic. To meet this lofty […].
pharmaphorum
OCTOBER 28, 2020
Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics. Exact Sciences said it has agreed to buy Thrive for a cash and stock deal worth up to $2.15 billion, positioning it as a leader in the cancer-screening market. The Madison-based company has made no secret of its ambitions to become the top player in the liquid biopsy space.
Scienmag
OCTOBER 28, 2020
ROCKVILLE, MD — With the COVID-19 pandemic still raging worldwide, members of the American Society of Human Genetics (ASHG) are working to understand how the virus spreads and infects people, why there is so much variability in susceptibility and severity, and where to look for potential therapeutics. Researchers presented the results of several studies relevant […].
BioSpace
OCTOBER 28, 2020
On October 14th, Amolyt Pharma announced the first dosing in its Phase I trial of AZP-3601 in healthy subjects, a momentous occasion capping off years of hard work in pre-clinical development. The drug aims to walk the biological tightrope in the management of hypoparathyroidism, a rare disease c.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
OCTOBER 28, 2020
Findings offer new clues for targeting drug resistant colon cancers Credit: ChristianaCare In breakthrough colon cancer research, scientists at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have discovered a link between two key signaling pathways crucial to the development and growth of colon cancer. The study is published today in the journal PLOS […].
BioSpace
OCTOBER 28, 2020
Shanghai-based LianBio raised $310 million in an oversubscribed crossover financing round less than two months after the company launched.
Scienmag
OCTOBER 28, 2020
Like looking at stars during the night instead of daytime Aim to detect cancer at an earlier, more treatable stage 700,000 in U.S. living with brain tumors CHICAGO — A new three-dimensional imaging technique has been developed that greatly improves the visibility of brain tumors in magnetic resonance imaging (MRI) scans. The technique, invented by […].
BioSpace
OCTOBER 28, 2020
Syneos Health announced on Wednesday that it has agreed to acquire Synteract, a full-service Contract Research Organization (CRO) focused on the biopharmaceutical industry.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
331 
Let's personalize your content